|PhandTA 9, the 9th
International Conference on Pharmacy and Applied Physical
Chemistry, is a Forum for Scientists and Experts.
aspects such as the Discovery and Screening of New Chemical
Entities and the physicochemical, galenical and preclinical
Characterization of Drug Substances, Drug Products and
Excipients will be presented and discussed. In addition,
investigations and research concerning the transport and the
bioavailability of Drug Substances are outlined as well as the
different forms of Delivery Systems.
The Conference intends to
create a platform for an interaction between Researchers
incorporated in the Academia and Scientists and Experts from
Research, Development and Regulatory Departments of the Life
Science Industry. The increasing pressure for extremely
efficient Drug Substances and Drug Products of a high quality
affords outstanding research activities and in addition
development procedures focused on analytical, chemical,
physicochemical and galenical characterizations. The
development tasks are rather complex because of the extreme
demands in respect to the chemical and physical stability as
the criteria for a high and constant bioavailability under the
storage and dispensation conditions.
The definition of patentable subjects and the disclosure of
molecular structures with an outstanding therapeutic activity
without revealing adverse side effects is another important
aspect. However, in addition to the basic molecular structures
as free bases or free acids, also entities such as hydrates,
solvates, salt forms, complexes, molecular compounds may be
taken into consideration for a disclosure. These aspects
should be considered in contact with the research and
Many of the above mentioned additional entities of a basic
molecular structure may be appearing in different polymorphic
forms. These additional solid state forms may range from
crystal structures with nearly identical properties to crystal
structures revealing drastic differences in their properties.
As an example for two solid state forms with rather different
properties - one case among a large number which could be
selected – is the case of Ritonavir (Norvir®). One of these
solid state forms of Ritonavir showed a bioavailability being
close to zero, which caused a severe problem.
Lectures are also welcome which give overviews in the
different areas of research and development as well as in the
physicochemical aspects of the manufacturing processes of
active substances, such as crystallization, phase separation,
lyophilization, drying and especially spray drying and freeze
drying. Also included in our Scientific Program are
preformulation and formulation processes for different types
of dosage forms.
The analytical, physicochemical and preclinical Methods and
Procedures are also in the focus of the Conference.
A Scientific Program offering Plenary Lectures, Key and Short
Communications as well as Poster Sessions anticipates an
exchange of information.
The program consists of the following sections:
Excipients and Polymers
Site-specific Drug Delivery
Methods of Physical Chemistry
You are cordially invited to participate in the PhandTA
Manufacturers of Instruments will
exhibit their newest developments during the instrumental
Service Organizations will show their capabilities and
will present their achievements.
The conference language will be English.